Chargement de la fiche…
Chargement de la fiche…
Hospitalo-universitaire
Photo : Jcb-caz-11, CC BY-SA 4.0, Wikimedia Commons
Dans les médias
Vous êtes Pr Alain Cantagrel ? Présentation, expertises, actes, site du cabinet : faites de cette fiche la page de votre cabinet.
Configurer votre fiche gratuitement →Pr Alain Cantagrel est rhumatologue à Castelnaudary (11400). Il consulte à CH JP CASSABEL CASTELNAUDARY, 19 Avenue MONSEIGNEUR DE LANGLE, 11400 Castelnaudary.
Consulter
CH JP CASSABEL CASTELNAUDARY
19 Avenue MONSEIGNEUR DE LANGLE, 11400 Castelnaudary
Pr Alain Cantagrel, c'est vous ?
Faites de cette fiche la page de votre cabinet.
Libéral
Pour aller plus loin
Remboursement
Pratique
Thèmes de publication
Domaines déduits des publications référencées sur PubMed.
Faits issus de registres publics et des déclarations du praticien — aucun classement.
Rhumatologie (SM) — Diplôme d'études spécialisées
DE Docteur en médecine — Capacité / certificat d'études spéciales
Les plus citées
2021JAMA network open100 citations
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19
2018Archives of physical medicine and rehabilitation79 citations
Effectiveness of Exercise Programs in Ankylosing Spondylitis: A Meta-Analysis of Randomized Controlled Trials
2019Joint bone spine77 citations
Update of French society for rheumatology recommendations for managing rheumatoid arthritis
Contenus publics où le nom du praticien apparaît (YouTube, Google Actualités).
En bref
Pr Alain Cantagrel consulte à CH JP CASSABEL CASTELNAUDARY, 19 Avenue MONSEIGNEUR DE LANGLE, 11400 Castelnaudary. Adresses issues de l'Annuaire Santé (ANS).
Par téléphone au 04 68 94 57 52 (numéro publié à l'Annuaire Santé). Un lien de recherche Doctolib est proposé sur cette page : si le praticien y est inscrit, son profil figure normalement parmi les résultats.
Identité, diplômes et lieux d'exercice : Annuaire Santé (ANS, licence ouverte). Conventionnement et carte Vitale : Assurance Maladie. Publications : bases scientifiques publiques (PubMed, HAL, OpenAlex), affichées seulement si le nom du praticien figure parmi les auteurs. Le praticien peut corriger sa fiche ou en demander le retrait à tout moment ; en cas d'homonymie, signalez-le.
Autour du cabinet
Vous pouvez aussi demander le retrait de la fiche.
Aperçu de votre présentation
Rhumatologue à Castelnaudary, j'accompagne…
Exemple : vous choisissez vos propres domaines.
Evidence for Pro-Inflammatory Activity of LTα3 on Macrophages: Significance for Experimental Arthritis and for Therapeutic Switching in Rheumatoid Arthritis Patients
2021JAMA network openPubMed
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19
2021iSciencePubMed
Evidence for tmTNF reverse signaling in vivo: Implications for an arginase-1-mediated therapeutic effect of TNF inhibitors during inflammation
2021Revue du rhumatisme (Ed. francaise : 1993)PubMed
Prise en charge des patients atteints de maladies rhumatismales pendant la pandémie de COVID-19 : la Société française de rhumatologie répond aux questions fréquentes posées jusqu’en mai 2020
2020Joint bone spinePubMed
Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020
2020RMD openPubMed
Part of pain labelled neuropathic in rheumatic disease might be rather nociplastic
2020Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral ResearchPubMed
Inhibition of Osteoclastogenesis by the RNA-Binding Protein QKI5: a Novel Approach to Protect from Bone Resorption
2020Journal of the European Academy of Dermatology and Venereology : JEADVPubMed
Early-onset granulomatous arthritis, uveitis and skin rash: characterization of skin involvement in Blau syndrome
2019Frontiers in immunologyPubMed
Corrigendum: Rheumatoid Synovial Fluids Regulate the Immunomodulatory Potential of Adipose-Derived Mesenchymal Stem Cells Through a TNF/NF-κB-Dependent Mechanism
2019Frontiers in immunologyPubMed
Rheumatoid Synovial Fluids Regulate the Immunomodulatory Potential of Adipose-Derived Mesenchymal Stem Cells Through a TNF/NF-κB-Dependent Mechanism
2019Seminars in arthritis and rheumatismPubMed
Characteristics and clinical outcomes after treatment of a national cohort of PCR-positive Lyme arthritis
2019Joint bone spinePubMed
Two-year abatacept retention rate in clinical practice in the French ACTION cohort
2019The pharmacogenomics journalPubMed
A single nucleotide polymorphism of IL6-receptor is associated with response to tocilizumab in rheumatoid arthritis patients
2018Rheumatology (Oxford, England)PubMed
Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data
2017RMD openPubMed
Real-world predictors of 12-month intravenous abatacept retention in patients with rheumatoid arthritis in the ACTION observational study
2017RMD openPubMed
Impact of gender on the response and tolerance to abatacept in patients with rheumatoid arthritis: results from the 'ORA' registry
2017Joint bone spinePubMed
The effect of body mass index on clinical response to abatacept as a first-line biologic for rheumatoid arthritis: 6-month results from the 2-year, observational, prospective ACTION study
2017Rheumatology (Oxford, England)PubMed
A rare case of rheumatoid pachyleptomeningitis successfully treated with rituximab
2017Rheumatology (Oxford, England)PubMed
Safety of surgery in patients with rheumatoid arthritis treated by abatacept: data from the French Orencia in Rheumatoid Arthritis Registry
2021Clinical and experimental rheumatologyPubMed
BENEFIT: real-world effectiveness of SB4 after transition from reference etanercept in rheumatoid arthritis and axial spondyloarthritis
2020Clinical and experimental rheumatologyPubMed
Biological DMARD efficacy in psoriatic arthritis: a systematic literature review and meta-analysis on articular, enthesitis, dactylitis, skin and functional outcomes
2019European radiologyPubMed
Prevalence of inflammatory posterior arch abnormalities on lumbar spine MRI in spondyloarthritis patients compared with low back pain patients
2019Arthritis research & therapyPubMed
Association between IL23R and ERAP1 polymorphisms and sacroiliac or spinal MRI inflammation in spondyloarthritis: DESIR cohort data
2018Archives of physical medicine and rehabilitationPubMed
Effectiveness of Exercise Programs in Ankylosing Spondylitis: A Meta-Analysis of Randomized Controlled Trials
2017RMD openPubMed
Relationships between ultrasound enthesitis, disease activity and axial radiographic structural changes in patients with early spondyloarthritis: data from DESIR cohort
2025Advances in therapyPubMed
Real-World Effectiveness and Safety of Infliximab Biosimilar CT-P13 for Rheumatic Diseases: A National Observational Cohort Study (ReFLECT)
2022Joint bone spinePubMed
Changes in etanercept and adalimumab biosimilar prescriptions for the initial treatment of rheumatoid arthritis in France: Data from the ART-SFR Registry
2021Clinical and experimental rheumatologyPubMed
BENEFIT: real-world effectiveness of SB4 after transition from reference etanercept in rheumatoid arthritis and axial spondyloarthritis
2017Joint bone spinePubMed
Infectious risk associated to orthopaedic surgery for rheumatoid arthritis patients treated by anti-TNFalpha
2020Clinical and experimental rheumatologyPubMed
Biological DMARD efficacy in psoriatic arthritis: a systematic literature review and meta-analysis on articular, enthesitis, dactylitis, skin and functional outcomes
2019RMD openPubMed
Short-term risk of major adverse cardiovascular events or congestive heart failure in patients with psoriatic arthritis or psoriasis initiating a biological therapy: a meta-analysis of randomised controlled trials
2018Journal of the European Academy of Dermatology and Venereology : JEADVPubMed
Psoriatic arthritis screening by the dermatologist: development and first validation of the 'PURE-4 scale'
2025 · Article
Evidence for Pro-Inflammatory Activity of LTα3 on Macrophages: Significance for Experimental Arthritis and for Therapeutic Switching in Rheumatoid Arthritis Patients
2025 · Article
Predicting Clinical Response to Monoclonal TNF Inhibitors in Rheumatoid Arthritis: A Transcriptomic Approach Based on Transmembrane TNF Reverse Signaling and Nrf2 Activation
2025 · Article
Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter Study
2024 · Article
Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohort
2022 · Article
Serum Fatty Acid Profiles Are Associated with Disease Activity in Early Rheumatoid Arthritis: Results from the ESPOIR Cohort
2022 · Article
Changes in etanercept and adalimumab biosimilar prescriptions for the initial treatment of rheumatoid arthritis in France: Data from the ART-SFR Registry
2021 · Article
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19
2021 · Article
Evidence for tmTNF reverse signaling in vivo
Publications affichées uniquement lorsque le nom du praticien figure parmi les auteurs. Une erreur d'homonymie ? Signalez-la depuis le lien en bas de page.